Sunshine Biopharma Inc. (NASDAQ:SBFM) finished Thursday with a subtraction of -$0.01 to close at $0.51, a downside of -2.29 percent. An average of 758,801 shares of common stock have been traded in the last five days. There was a gain of $0.0450 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 273,720 shares traded, while the 50-day average volume stands at 223,064.
SBFM stock has decreased by -2.10% in the last month. The company shares reached their 1-month lowest point of $0.4500 on 07/28/23. With the stock rallying to its 52-week high on 05/11/23, shares of the company touched a low of $0.45 and a high of $1.47 in 52 weeks. It has reached a new high 11 times so far this year and lost -20.61% or -$0.1100 in price. In spite of this, the price is down -65.44% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Sunshine Biopharma Inc. (SBFM) stock’s beta is -0.94. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.30, the price-to-book (PB) ratio at 0.58.
Financial Health
The quick ratio of Sunshine Biopharma Inc. for the recent quarter was 3.10, and the current ratio was 3.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the recent quarter. Sunshine Biopharma Inc.’s EBITDA margin is -199.03%. Its gross profit as reported stood at $1.7 million compared to revenue of $4.35 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sunshine Biopharma Inc.’s return on assets was -78.30%.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$0.9 million in the quarter, while revenues of -$1.7 million were grew 40.0%. Shareholders own equity worth $22.14 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sunshine Biopharma Inc. (SBFM) price momentum. RSI 9-day as of the close on 10 August was 61.67%, suggesting the stock is Neutral, with historical volatility in this time frame at 52.94%.
As of today, SBFM’s price is $0.5197 +9.28% or $0.0450 from its 5-day moving average. SBFM is currently trading +10.35% higher than its 20-day SMA and -32.05% lower than its 100-day SMA. However, the stock’s current price level is -13.11% below the SMA50 and -45.64% below the SMA200.
The stochastic %K and %D were 68.71% and 76.72%, respectively, and the average true range (ATR) was 0.0496. With the 14-day stochastic at 41.03% and the average true range at 0.0463, the RSI (14) stands at 56.46%. The stock has reached 0.0146 on the 9-day MACD Oscillator while the 14-day reading was at 0.0278.
